CM
Caption Management Portfolio holdings
AUM
$1.09B
This Quarter Return
+2.11%
1 Year Return
+4.13%
3 Year Return
+12.18%
5 Year Return
+25.84%
10 Year Return
–
AUM
$1.09B
AUM Growth
+$1.09B
(-50%)
Cap. Flow
-$1.2B
Cap. Flow
% of AUM
-110.09%
Top 10 Holdings %
Top 10 Hldgs %
25.17%
Holding
1,115
New
230
Increased
115
Reduced
111
Closed
247
Top Buys
| 1 |
Insmed
INSM
|
$21.2M |
| 2 |
Skechers
SKX
|
$20.1M |
| 3 |
Gilead Sciences
GILD
|
$16.5M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
$16.4M |
| 5 |
Kellanova
K
|
$14.9M |
Top Sells
| 1 |
Microsoft
MSFT
|
$394M |
| 2 |
Amazon
AMZN
|
$314M |
| 3 |
NVIDIA
NVDA
|
$255M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
$130M |
| 5 |
Cisco
CSCO
|
$61.7M |
Sector Composition
| 1 | Healthcare | 25.54% |
| 2 | Consumer Discretionary | 20.68% |
| 3 | Technology | 13.45% |
| 4 | Financials | 8.7% |
| 5 | Communication Services | 6.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Appian
APPN
$2.28B
| $2.4M | 0.03% | 80,472 -14,242 | -15% | -$425K |
|
127
Alamos Gold
AGI
$12.8B
| $2.38M | 0.03% | 89,591 -72,284 | -45% | -$1.92M |
|
128
ING
ING
$70.3B
| $2.37M | 0.03% | 108,500 | – | – |
|
|
AVDL
129
Avadel Pharmaceuticals
AVDL
$1.43B
| $2.34M | 0.03% | 264,910 | – | – |
|
130
CoStar Group
CSGP
$37.9B
| $2.33M | 0.03% | 29,000 +13,552 | +88% | +$1.09M |
|
131
AES
AES
$9.64B
| $2.32M | 0.03% | 220,300 +211,000 | +2,269% | +$2.22M |
|
|
132
Alphabet (Google) Class A
GOOGL
$2.57T
| $2.27M | 0.03% | 12,900 -738,750 | -98% | -$130M |
|
133
Urban Outfitters
URBN
$6.02B
| $2.27M | 0.03% | +31,300 | New | +$2.27M |
|
134
The GEO Group
GEO
$2.94B
| $2.25M | 0.02% | 93,843 +93,058 | +11,855% | +$2.23M |
|
135
Franco-Nevada
FNV
$36.3B
| $2.17M | 0.02% | 13,245 +8,245 | +165% | +$1.35M |
|
136
Globus Medical
GMED
$8.27B
| $2.15M | 0.02% | +36,507 | New | +$2.15M |
|
137
MetLife
MET
$54.1B
| $2.13M | 0.02% | +26,500 | New | +$2.13M |
|
138
Recursion Pharmaceuticals
RXRX
$2.04B
| $2.13M | 0.02% | +420,801 | New | +$2.13M |
|
139
NextNav
NN
$2.37B
| $2.06M | 0.02% | 135,478 -72,954 | -35% | -$1.11M |
|
140
Groupon
GRPN
$1.06B
| $2.05M | 0.02% | 61,282 -433,958 | -88% | -$14.5M |
|
141
Baxter International
BAX
$12.7B
| $2.04M | 0.02% | +67,500 | New | +$2.04M |
|
142
Synchrony
SYF
$28.4B
| $2M | 0.02% | +30,000 | New | +$2M |
|
143
Larimar Therapeutics
LRMR
$310M
| $1.99M | 0.02% | +689,290 | New | +$1.99M |
|
144
Brighthouse Financial
BHF
$2.7B
| $1.99M | 0.02% | +37,000 | New | +$1.99M |
|
145
British American Tobacco
BTI
$124B
| $1.99M | 0.02% | +42,000 | New | +$1.99M |
|
146
Amphenol
APH
$133B
| $1.98M | 0.02% | 20,000 +12,000 | +150% | +$1.19M |
|
147
ADMA Biologics
ADMA
$4.12B
| $1.97M | 0.02% | +108,000 | New | +$1.97M |
|
148
Allot
ALLT
$362M
| $1.93M | 0.02% | 226,146 -44,435 | -16% | -$380K |
|
149
National Vision
EYE
$1.82B
| $1.91M | 0.02% | 83,000 -14,099 | -15% | -$324K |
|
150
CAE Inc
CAE
$8.64B
| $1.9M | 0.02% | +65,000 | New | +$1.9M |
|